Background
Diabetes Mellitus is a metabolic disease leading to such complications as neuropathy, retinopathy, and nephropathy. According to the UK Prospective Diabetes Study (UKPDS) data, micro vascular complications are revealed when diabetes is diagnosed, which is associated with late diagnosis of the disease [1] . Also, diabetes is associated with an increased risk of dementia especially in groups where mild cognitive impairments have been diagnosed [2, 3] . But, unfortunately, though retinal microcirculation disorders can be diagnosed at the early stage, cerebral circulation disorders with cognitive impairment development are diagnosed at a rather late stage when structural changes develop in the brain of the patients. Recent researches on association between cognitive impairment (CI) and diabetic retinopathy (DR) have received conflicting data [4, 5] . The presence of DR has been shown to increase a risk of mild cognitive impairment (MCI) development more than twice (OR 2.36) [6] . A systematic review, including six studies, has also determined the increase in cognitive impairment risk (OR -2.0) in type 2 diabetes patients with DR [7] . Another study has found the association between DR and MCI only in male subjects [8] . Also, cognitive dysfunction has been more apparent in patients with mild DR signs than in a group of severe DR [9] . Furthermore, the most authors have investigated the cognitive function by studying memory, information and operation processing speed not taking into consideration the sensitivity of tests in this group of patients.
The purpose of the present study was to investigate the state of cognitive function in type 2 diabetes patients with DR and to determine the most sensitive cognitive tests. 
Material and Methods
The study included 93 patients with type 2 diabetes, aged 50 to 80. The patients were divided into two groups: DR-group and non-DR group. Exclusion criteria were the presence of another diabetes type, alcohol abuse, craniocerebral trauma, a history of insult, professional diseases that could affect the study, and depressive disorders.
In order to reveal the depressive disorders, we used two questionnaires:
• Centre for Epidemiologic Studies Depression Scale (CES-D)
• Statistical data processing was performed using SPSS version 23.0 for Windows. A general linear model (UNIANOVA), adjusted for age, educational level, and gender, was used to compare DR-group and non-DR-group. T-test was also used to compare the data between groups. The difference between parameters was considered significant with р<0.05.
Results and Discussion
The patients had no statistically significant difference between groups in regard to age, education level, and disease duration. Characteristics of patients are given in Table 1 . The data are given as Mean value ± error of mean (М±m).
As it can be seen in Table 2 , no significant difference was found in cognitive function between groups of patients according to FAB, MMSE, the clock drawing test, the "five words" test, the Verbal fluency test, DSFB, the Stroop color test, and the Тest symbооl. At the same time, when performing the "fifteen words" test, which is similar to the "five words" test, it was significantly better performed by patients in DR-group. Thus, shortterm and long-term memory was in a significantly better condition in DR patients than in non-DR patients, while recognition function did not differ in the groups.
This test is very sensitive and useful for assessing the verbal learning and memory, including proactive inhibition, retroactive inhibition, retention, encoding, and subjective organization. It can be supposed that, in patients with DR, other, i.e. aural, ways for memorizing are activated due to vision impairment. On the other hand, when performing TMT, which can assess visual search speed, perception, speed of processing, working memory, and general intelligence, the better results were obtained in non-DR group of patients. Thus, TMT Part A, which can assess visual processing speed, revealed no difference between groups; however, TMT Part B showed significantly better results in non-DRgroup of patients, so this group patients had better working memory and mental flexibility. TMT BA can assess visuoperceptual and working memory, providing a relatively pure indicator of executive abilities [11, 12, 13] , which also were better in the non-DR-group. Poor performance of this test by DR-group of patients showed that they had more pronounced lesions in the frontal area as compared to non-DR patients. The Brixton test confirmed significant impairment in executive functions in DR-group patients in comparison with non-DR patients. Executive functions are cognitive processes which control other kinds of the brain activity and mainly activate prefrontal regions of the frontal lobes. These functions are responsible for initiative, consolidative, regulative, verbal, motional and emotional processes [14] . In turn, these processes are the basis for such functions as planning, self-feeling, problem solving, strategy selecting or sequence of behaviors for achievement of chosen goals [1, 4, 5] . This is very important since DM patients are patients with a chronic disease and have to make every-day decisions about selfcontrol and antihyperglycemic therapy which is crucial for DM compensation and disability relief.
Conclusions

1.
Relationship between the presence of DR and impairment of cognitive functions in type 2 diabetes patients was revealed.
2. The patients with DR had worse rates of working memory and memory flexibility as well of executive functioning according to the TMT and the Brixton test.
3. Poor performance of the TMT and the Brixton test by the DR patients indicated the lesions in frontal and perifrontal areas of the cortex.
4. The Brixton test is recommended to perform in order to screen cognitive impairments in type 2 diabetes patients with DR since this test seems to be more sensitive and easy to perform. It can be used in patients who have problems with counting and reading. 
